![Adesh Kaul](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adesh Kaul
Director of Finance/CFO at
BASILEA PHARMACEUTICA AG
Net worth: 1 M $ as of 31/05/2026
Profile
Currently, Adesh Kaul is Chief Financial Officer at Basilea Pharmaceutica AG since 2019, with employment at the firm starting in 2009.
Formerly, Mr. Kaul was CFO & Head-Corporate Development at Spexis Ltd. from 2015 to 2016.
Also worked as a Research Analyst at NZB Neue Zürcher Bank AG (Investment Management) and NZB Neue Zürcher Bank AG.
Education includes an MBA from the University of St. Gallen and a graduate degree from the University of Basel.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 16,205 ( 0.12% ) | 1 M $ | 31/05/2026 |
Adesh Kaul active positions
| Companies | Position | Start |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Director of Finance/CFO | 10/04/2019 |
Former positions of Adesh Kaul
| Companies | Position | End |
|---|---|---|
| SPEXIS AG | Director of Finance/CFO | 01/01/2016 |
NZB Neue Zürcher Bank AG (Investment Management)
 NZB Neue Zürcher Bank AG (Investment Management) Major BanksFinance NZB-IM is an active manager which follows a top-down approach. Their investment focus is on the Swiss market. The investment managers use both quantitative and qualitative factors to construct value-oriented portfolios for long-term returns. In addition to their in-house team, they utilize external sources such as experts in taxation, legal, estate- and retirement-planning. | Analyst-Equity | - |
NZB Neue Zürcher Bank AG
 NZB Neue Zürcher Bank AG Investment Banks/BrokersFinance Provides securities and brokerage services | Analyst-Equity | - |
Training of Adesh Kaul
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
NZB Neue Zürcher Bank AG (Investment Management)
NZB Neue Zürcher Bank AG (Investment Management) Major BanksFinance NZB-IM is an active manager which follows a top-down approach. Their investment focus is on the Swiss market. The investment managers use both quantitative and qualitative factors to construct value-oriented portfolios for long-term returns. In addition to their in-house team, they utilize external sources such as experts in taxation, legal, estate- and retirement-planning. | Finance |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
NZB Neue Zürcher Bank AG
NZB Neue Zürcher Bank AG Investment Banks/BrokersFinance Provides securities and brokerage services | Finance |
- Stock Market
- Insiders
- Adesh Kaul
